Eric Laffon

16PUBLICATIONS
1CO-AUTHORS
Heliophysics and space weatherInteractive narrativeProbability theoryCancer therapy (excl. chemotherapy and radiation therapy)Veterinary diagnosis and diagnostics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 03, 2022
On the factors affecting the liver SUV in [<sup>18</sup>F]FDG PET/CT imaging.

Eric Laffon, Henri de Clermont, Roger Marthan

|Oct 11, 2022
<sup>64</sup>Cu-/<sup>177</sup>Lu-Cetuximab Theranostic Pair: May the Single <sup>64</sup>Cu-Cetuximab Diagnostic Scan Be Acquired at Any Time After Injection?

Eric Laffon, Roger Marthan

|May 20, 2022
Estimation of Cumulative Activity of <sup>177</sup>Lu-Cetuximab from a Single Diagnostic <sup>64</sup>Cu-Cetuximab Scan.

Eric Laffon, Roger Marthan

|Aug 21, 2021
An abbreviated therapy-dosimetric equation for the companion diagnostic/therapeutic [<sup>64/67</sup>Cu]Cu-SARTATE.

Eric Laffon, Henri de Clermont, Roger Marthan

|Apr 20, 2021
Is There a Relevant Imaging Time for Optimal Quantitative <sup>89</sup>Zr-DFO-Daratumumab PET Imaging?

Eric Laffon, Roger Marthan

|Feb 26, 2021
Correction to: Is Patlak y-intercept a relevant metrics?

Eric Laffon, Roger Marthan

Pageof 3

Frequent Collaborators

1 joint publications

Roger Marthan